Wed, 06 Aug 2008 23:58:35 GMT
San Francisco Mayor Gavin Newsom has announced that Pfizer Inc. will relocate its biotech research center to the city, a move leaders hope will attract other biomedical businesses.
Wed, 06 Aug 2008 19:52:49 GMT
Under continued pressure to cut costs, Eli Lilly and Co. is selling its sprawling Greenfield Laboratories, which it has run for nearly a century, to a New Jersey company that will continue to operate it and ...
Wed, 06 Aug 2008 15:38:58 GMT
The average time that hospital emergency rooms patients wait to see a doctor has grown from about 38 minutes to almost an hour over the past decade, according to new federal statistics released Wednesday.
Wed, 06 Aug 2008 11:32:36 GMT
Main Category: HIV / AIDS Also Included In: Clinical Trials / Drug Trials ; Pharma Industry / Biotech Industry Article Date: 05 Aug 2008 - 1:00 PDT Monogram Biosciences, Inc.
Wed, 06 Aug 2008 07:30:29 GMT
By Susan Heavey
WASHINGTON (Reuters) - U.S. health regulators have approved six versions of the influenza vaccine to help combat the virus during the 2008-2009 flu season later this year.
The vaccines include GlaxoSmithKline Plc's Fluarix and FluLaval; Novartis AG's Fluvirin; Sanofi Aventis SA's Fluzone and CSL Ltd's Afluria, the U.S. Food and Drug Administration said on Tuesday.
The FDA also cleared the FluMist nasal spray flu vaccine made by AstraZeneca Plc unit MedImmune.
Each vaccine contains the same three strains of the influenza virus, which experts choose every year after weighing which ones are most likely to break out. Experts include two strains from Type A, an H1N1 and an H3N2 version, and one for Type B.
Wed, 06 Aug 2008 03:27:20 GMT
An international drug maker has laid off 22 more employees at its North Carolina research facility following an earlier summer dismissal of scientific workers, a newspaper reported Tuesday.
Tue, 05 Aug 2008 23:10:26 GMT
VIVUS, Inc. , a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced that it has entered into definitive agreements dated August 5, 2008 with ...
Tue, 05 Aug 2008 19:07:38 GMT
ACADIA Pharmaceuticals Inc. , a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today ...
Tue, 05 Aug 2008 15:01:44 GMT
Stock market regulator Securities and Exchange Board of India on Monday allowed Japanese drug major Daiichi Sankyo to go ahead with an open offer to acquire 20 per cent stake in Ranbaxy Laboratories, sources ...
Tue, 05 Aug 2008 11:00:59 GMT
The National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health has published several new resources to help people learn more about urologic and kidney disorders.
Tue, 05 Aug 2008 06:49:57 GMT
MDRNA Inc., of Bothell, said Monday that it would lay off 23 employees, including its president and chief business officer, as the biotech company continues to restructure around its RNA interference programs, ...
Tue, 05 Aug 2008 02:43:49 GMT
A drug manufactured by Alkermes Inc. to treat alcoholism has gained marketing approval in Russia.
Thu, 07 Aug 2008 20:44:37 GMT
Health officials said Thursday that they are investigating a dozen possible cases of typhus in Travis County, further north than the disease is usually seen in Texas.
Thu, 07 Aug 2008 16:38:03 GMT
Barr Pharmaceuticals Inc., the drug company that has operations in Pomona, earned $57 million, or 52 cents a share, in the second quarter, compared with a profit of $45 million, or 41 cents a share, a year ...
Thu, 07 Aug 2008 12:18:44 GMT
Main Category: Cardiovascular / Cardiology Also Included In: Pharma Industry / Biotech Industry GlaxoSmithKline announced that a review of data from over 14,600 patients in 54 clinical studies showed no ...
Thu, 07 Aug 2008 08:02:57 GMT
C ambridge's Verenium Corp. has more money to burn. The "cellulosic" ethanol company announced yesterday that BP PLC will invest $90 million over the next 18 months to help Verenium develop its cutting-edge ...
Thu, 07 Aug 2008 04:02:00 GMT
Patients in the United States made an estimated 1.1 billion visits to physician offices and hospital outpatient and emergency departments in 2006, an average of four visits per person per year, according to new ...
Mon, 04 Aug 2008 22:36:34 GMT
Schering's drug, boceprevir, is the closest competitor to Vertex's experimental hepatitis C drug telaprevir and, although Vertex is further ahead in development, investors are closely watching the competitive ...
Mon, 04 Aug 2008 18:31:38 GMT
SGX Pharmaceuticals, we hardly knew you. On Tuesday, Eli Lilly announced its purchase of the development-stage drugmaker, which had its IPO in 2006.
Mon, 04 Aug 2008 14:15:48 GMT
Cleviprex, a novel IV antihypertensive, represents an advancement over currently available therapies, providing rapid and precise control of blood pressure in the critical care setting.
Home > News